UBS Group’s BriaCell Therapeutics Corp. Warrant BCTXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.26K Buy
+1,189
New +$1.26K ﹤0.01% 8322